Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Samator Indo Gas Tbk (AGII) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Samator Indo Gas Tbk
Tempo Scan Pacific Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Samator Indo Gas Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Samator Indo Gas Tbk trades at Rp3,080 (market cap 9.94T, 828.9K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,470 (market cap 11.23T, 699.1K 24h volume). The key difference: Samator Indo Gas Tbk and Tempo Scan Pacific Tbk. are close in size by market cap, and Samator Indo Gas Tbk is more actively traded (828.9K versus 699.1K). Which is the better fit depends on your goals.

AGIITSPC
Market Cap
9.94T11.23T
Volume
828.9K699.1K
Lot
8.29K6.99K
Turnover
2.79B1.75B
Average Price
3,360.552,496.22
Value
2.79B1.75B
Indicative Equilibrium Price
3,0802,470
Indicative Equilibrium Volume
9790

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AGII
View details
TSPC
View details

About Samator Indo Gas Tbk

PT. Aneka Gas Industri Tbk (the Entity) was established based on the Notarial Deed No. 28 of Soeleman Ardjasasmita, S.H., dated September 21, 1971 in Jakarta. The Entity received permanent permit (SIUP) from Capital Investment Coordinating Board regarding the changes of the Entity's status from Foreign Capital Investment to Domestic Capital Investment in its Decision Letter No. 05/V/PMDN/2003 dated March 10, 2003.

Read more on AGII

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC